EndoTech

EndoTech

The recognized leader in algorithmic alternative investments using Artificial Intelligence

09/05/2024

🔊ΣNDOTECH PERFORMANCE REPORT FOR APRIL 2024
https://endotech.io/performance-report-for-april-2024/

In April 2024
*New AI Modules Prove Their Value Contextualizing Sentiment and News
Because of the enormous impact fundamental analysis has on cryptocurrency prices, Dr. Becker's team has improved their ability to ingest, normalize, and weigh different pieces of fundamental analysis. The AI modules that perform this analysis have been upgraded, and their performance has been proven throughout the very noisy ETF regulation and Bitcoin Halving season. Having the ability to properly understand and decide based on sentiment, news, and regulation is key to AI values.

*Institutional Investors Moving from 'Crypto Exposure' to 'AI Investing'
Over the years, institutional investors have made a point of having exposure to the new asset category. And, of course, with the ETF launch, they have been able to participate more easily than ever. One of the trends we are seeing is that these same investors are now looking to do better: to capitalize on the volatility of the asset class, not just have a 'buy and hold' approach that leaves them susceptible to market swings.

*Dr. Anna Becker Speaks with American Banker about AI
As AI becomes more mainstream, financial institutions look to understand how they can use its power for multiple purposes - from customer service to security to investment decision-making. Leading financial publication, American Banker, sits down with Dr. Anna Becker and gets her perspective on the future of AI in banking and how it will change the role of investment professionals. https://www.americanbanker.com/opinion/yes-ai-is-coming-for-your-job-heres-why-you-shouldnt-worry

18/04/2024

🔊ΣNDOTECH PERFORMANCE REPORT FOR MARCH 2024
https://endotech.io/performance-report-for-march-2024/

In March 2024
*Bitcoin Halving Volatility Opportunities
With crypto markets attracting more institutional attention ahead of the upcoming Bitcoin halving, there are substantial market price swings. We have seen renewed volatility, and EndoTech's algorithms remain responsive to these new market dynamics. This volatility presents an opportunity for investors to adopt a more alpha-oriented approach to investing in digital currencies, moving beyond the traditional roller-coaster buy-and-hold strategy.

*New AI Capability: Market State Predictions
Market states represent the general context of a market, providing a more defined picture of current market conditions. They enable other AI modules to optimize information ingestion and decision-making. Thanks to the dedicated efforts and advancements in AI, Dr. Becker's quant team is now developing iterative market simulations that predict upcoming market states. This breakthrough in data processing and analysis is currently in the piloting phase, representing a significant advancement with an order of magnitude increase in parameters.

*EndoTech's Industry Leadership
Dr. Anna Becker and Dmitry Gooshchin have been featured in numerous publications discussing the growth of cryptocurrencies, particularly among institutional investors. They have been cited in leading technology and financial publications covering topics such as the adoption of ETFs, volatility preceding the Bitcoin halving, the role of AI in data analysis, and the increasing demand from institutions to generate alpha through volatility in this dynamic asset class. Our leaders were recently highlighted in publications including RTInsights, Securities, and Unite.Ai.

17/03/2024

🔊ΣNDOTECH PERFORMANCE REPORT FOR FEBRUARY 2024
https://endotech.io/performance-report-for-february-2024/

In February 2024
*Quant Funds Learn About EndoTech’s Unique Multivariate AI Approach
Over the past few months, EndoTech’s management has been engaging with different quant funds to discuss Dr. Becker’s unique approach. These conversations have showcased EndoTech’s breakthrough in multivariate AI analysis. The discussions highlight EndoTech platform’s ability to factor in more than 200 AI modules, as opposed to the traditional quant approach of a narrow single or duo-variable approach to algorithms.

*EndoTech Releases Upgraded Strategy Studio
EndoTech released its upgraded Strategy Studio with enhanced capabilities across its core components. The latest release features a more robust strategy studio, updated administration and risk control modules, and improved ex*****on performance. This reflects continued leadership from EndoTech’s quant development team, comprising over 40 professionals, and has been seamlessly deployed throughout our operations. These should strengthen EndoTech’s capacity to offer market contextualization and precise predictions.

*EndoTech’s AI Accomplishments Highlighted in the Press
As AI continues to integrate into mainstream business operations across financial services, EndoTech’s technology is attracting attention from journalists in financial and technology publications. EndoTech’s founders have been featured in publications for their efforts to expand the adoption of advanced AI among institutional investors. Recent coverage includes Morningstar, Digital Journal, and Entrepreneurs Break. To stay informed about industry coverage, join our social channels on Telegram, LinkedIn, and Twitter/X.

12/02/2024

🔊ΣNDOTECH PERFORMANCE REPORT FOR JANUARY 2024
https://endotech.io/performance-report-for-january-2024/

In January 2024
*EndoTech’s AI Models Now Live on Other Asset Classes
After over a decade of AI development, EndoTech has started engaging select money managers in other asset classes. Just as EndoTech pioneered institutional-grade AI investments for digital assets, we are now leading the charge for other liquid and leverageable assets. Institutional investors have been seeking repeatable, systematic ways to capture Alpha in these markets. If you are a certified money manager and would like to explore harnessing our AI for your portfolio, feel free to reach out our team.

*Institutional Investors Applaud Dr. Becker’s AI Innovation in the Press
As more asset allocators witness the results of using EndoTech’s AI platform, the company is gaining increased coverage in the investment press. Recently, Dr. Becker and her innovative AI platform have been featured in publications, including Yahoo Finance, Seeking Alpha, Digital Journal, FinExtra, and more. For a comprehensive list of our regular media coverage, join our dedicated social channels on Telegram, LinkedIn, and Twitter/X.

*New Investment Vehicles Now Available for Money Managers
Many investors have taken advantage of the secure self-custody solutions EndoTech offers. Now, with the influx of new institutional funds and collaboration with regulatory bodies, EndoTech is extending its investment technologies through additional vehicles. These vehicles enable tailored investments with full custody, regulatory oversight, and operational excellence to serve investors globally. If you are a money manager looking to leverage Alpha-seeking AI, feel free to reach out through our institutional channels at https://endotech.io/institutional/.

16/01/2024

🔊ΣNDOTECH PERFORMANCE REPORT FOR DECEMBER 2023
https://endotech.io/performance-report-for-december-2023/

In December 2023
*Involvement in New Crypto Regulation
While working behind the scenes, Dr. Becker and Dmitry Gooshchin actively contribute to enhancing various regulatory frameworks for crypto and digital assets. They consistently advocate for law enforcement and regulatory structures for crypto investments in various media outlets. Recently, Dmitry Gooshchin’s positions were recognized and celebrated in publications such as securities.io and others.

*EndoTech’s AI Models Now Training on Other Asset Classes
In light of the tremendous success EndoTech’s AI algorithms have achieved, and in response to institutional interest in applying these advanced quantitative techniques to other asset classes, Dr. Becker’s team has established a new department to apply the AI framework. Although EndoTech’s AI has been in development for a decade, the application is currently underway. Institutional investors interested in this approach for other highly liquid, volatile asset classes can visit https://endotech.io/institutional/.

*Ongoing Security Enhancements
As part of our ongoing efforts to ensure the security of your assets, the EndoTech team continually adds new security and authorization levels, including KYC and 2FA. It is essential to note that at no point will EndoTech have access to your funds; they are strictly controlled by you through secure API keys. Should you have any questions, feel free to reach out to our support team at [email protected].

19/12/2023

🔊ΣNDOTECH PERFORMANCE REPORT FOR NOVEMBER 2023
https://endotech.io/performance-report-for-november-2023/

In November 2023
*Algorithmic Fine-Tuning in Anticipation of ETF Approvals
In anticipation of the forthcoming ETF approvals, EndoTech's algorithmic team is currently fine-tuning its modeling. The expected approvals are anticipated in early 2024 and hinge on the approval of the SEC's Gary Gensler. If granted, these ETFs are projected to contribute to an upswing in trading volume.

*Incredible Uplift in German AI Adoption
We have recently concluded a series of discussions throughout Germany about our breakthrough AI, and the reception has been remarkably positive. Following the strong adoption of our AI solution in the German market, there has been a notable uptick in High Net Worth Individual (HNWI) and Family Office investments. This surge in investor interest has been accompanied by increased media recognition in the local market, with publications such as Yahoo Finance.de highlighting our accomplishments.

*Client Service Improvements
The EndoTech team has achieved a significant leap forward in the process of onboarding new clients, streamlining the API setup, and simultaneously enhancing security parameters. This improvement has already been experienced by our new clients. A heartfelt thank you to the UX and product team for their continued efforts in addressing these crucial usability issues and making notable progress.

04/12/2023

BTC ALPHA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 68 579.30
Annual Return % 200.75
Winning Months 26
Losing Months 9
https://endotech.io/en/strategies/

03/12/2023

4h Alpha ETH Leverage 10
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 465 429.00
Annual Return % 1562.20
Winning Months 27
Losing Months 8
https://endotech.io/en/strategies/

02/12/2023

4h Alpha BTC Leverage 10
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 202 062.00
Annual Return % 659.42
Winning Months 26
Losing Months 9
https://endotech.io/en/strategies/

01/12/2023

ETH/BTC Beta Leverage 4
PERFORMANCE
Initial Balance BTC 2.000000
Current Balance BTC 13.897600
Annual Return % 204.44
Winning Months 26
Losing Months 9
https://endotech.io/en/strategies/

30/11/2023

ETH BETA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 58 733.20
Annual Return % 167.63
Winning Months 28
Losing Months 6
https://endotech.io/en/strategies/

29/11/2023

ETH ALPHA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 79 477.50
Annual Return % 239.22
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

28/11/2023

BTC BETA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 39 477.50
Annual Return % 101.59
Winning Months 22
Losing Months 12
https://endotech.io/en/strategies/

27/11/2023

BTC ALPHA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 67 745.30
Annual Return % 199.20
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

26/11/2023

4h Alpha ETH Leverage 10
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 473 273.00
Annual Return % 1599.60
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

25/11/2023

4h Alpha BTC Leverage 10
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 201 105.00
Annual Return % 660.48
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

24/11/2023

ETH/BTC Beta Leverage 4
PERFORMANCE
Initial Balance BTC 2.000000
Current Balance BTC 13.981700
Annual Return % 207.24
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

23/11/2023

ETH BETA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 58 839.50
Annual Return % 169.11
Winning Months 28
Losing Months 6
https://endotech.io/en/strategies/

22/11/2023

ETH ALPHA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 79 791.20
Annual Return % 241.89
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

21/11/2023

BTC BETA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 39 045.20
Annual Return % 100.76
Winning Months 22
Losing Months 12
https://endotech.io/en/strategies/

20/11/2023

BTC ALPHA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 66 839.90
Annual Return % 197.38
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

19/11/2023

4h Alpha ETH Leverage 10
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 468 769.00
Annual Return % 1594.58
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

18/11/2023

4h Alpha BTC Leverage 10
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 199 260.00
Annual Return % 658.45
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

17/11/2023

ETH/BTC Beta Leverage 4
PERFORMANCE
Initial Balance BTC 2.000000
Current Balance BTC 13.939600
Annual Return % 207.89
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

16/11/2023

ETH BETA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 58 815.80
Annual Return % 170.16
Winning Months 28
Losing Months 6
https://endotech.io/en/strategies/

15/11/2023

ETH ALPHA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 80 530.20
Annual Return % 246.08
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

14/11/2023

BTC BETA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 39 542.80
Annual Return % 103.17
Winning Months 22
Losing Months 12
https://endotech.io/en/strategies/

13/11/2023

🔊ΣNDOTECH PERFORMANCE REPORT FOR OCTOBER 2023
https://endotech.io/performance-report-for-october-2023/

In October 2023

*Enhanced Security and Regulatory Processes
EndoTech prides itself on exceeding standard security procedures to ensure the utmost safety of all client funds. We have recently implemented an additional layer of verification to guarantee that all client interactions are verified, and access to funds is protected by the strictest security protocols.

*EndoTech’s AI Continues to Make Headlines
As global markets become more acquainted with AI concepts, various industries seek commentators and keynote speakers to discuss AI’s role in different fields. Dr. Anna Becker is consistently in demand for her groundbreaking ideas and technologies. She has been featured in over a dozen publications in recent months, including MarketWatch, Securities and Morningstar.

*Strategic Investor Developments
The recent regulatory progress that is paving the way for ETFs continues to stimulate increased institutional interest in cryptocurrency investments. Consequently, the EndoTech team has been actively collaborating with institutional investors to assist them in adopting a more informed approach to digital asset investing. We are delighted to welcome a growing number of family offices and high-net-worth individuals to the realm of AI-driven investments.

12/11/2023

BTC ALPHA
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 68 010.50
Annual Return % 202.98
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

11/11/2023

4h Alpha ETH Leverage 10
PERFORMANCE
Initial Balance USDT 10 000.00
Current Balance USDT 472 564.00
Annual Return % 1620.08
Winning Months 26
Losing Months 8
https://endotech.io/en/strategies/

Videos (show all)

The power of #Algos to capture the #ETH movement.